Submission of confirmation Appointment of Directors and secretarial Auditor.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has informed BSE about approvals passed at its 31st Annual General Meeting held on 19th September 2025. Shareholders approved the appointment of Mr. Gattu Gnana Prakash as Non-Executive Non-Independent Director; he is an IIT-Chennai graduate with over 25 years of experience in management and IT. Shareholders also approved the appointment of Ms. Mayuri Baidya as Non-Executive Independent Director for a 5-year term effective 14th August 2025; she holds a postgraduate degree in Commerce with experience in accounting and finance. Additionally, M/s Khushbu Kanwar & Co., Practicing Company Secretaries based in Jaipur, has been appointed as Secretarial Auditor for a 5-year period from April 01, 2025 to March 31, 2030. Neither new director is related to existing directors or KMPs, and neither is debarred by SEBI or any authority.
This is a routine governance update with new director and auditor appointments that strengthen board composition and compliance oversight. No material impact on stock price is expected as these are standard regulatory disclosures.